Mirtazapine
- Product NDC
- 71610-121
- 11-digit product format
- 716100121
- Labeler code
- 71610
- Product ID
- 71610-121_658b4bb3-7feb-4cd0-85e5-7d6096e601e1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mirtazapine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076312
- Marketing category
- ANDA
- Marketing start
- 2003-06-19
- Marketing end
- 0000-00-00
- Substance
- MIRTAZAPINE
- Active strength
- 15 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-121 | MIRTAZAPINE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20180906_dee6139c-4102-4b25-84c0-29390db7a8f7.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-121-09 | 71610012109 | 9000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-121-09) | 2018-08-15 | 0000-00-00 | No | No | Current |